Home / Drug shortages / Liraglutide Injection

Liraglutide Injection — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Liraglutide Injection (injection) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 05/14/2026.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0480-7250-46
Dosage Form
Injection
Presentation
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)
Initial Posting
05/14/2026
Revised Date

FDA data resources